|
|
|
| The treatment experience about central nervous system demyelinating disease remission of Professor Wang Lixin from the hidden pathogen theory |
| DAI Yueman1 WANG Lixin2▲ |
1.The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong Province, Guangzhou 510405, China;
2.the First Department of Neurology, Guangdong Hospital of Traditional Chinese Medicine, Guangdong Province, Guangzhou 510120, China |
|
|
|
Abstract Professor Wang Lixin has studied the demyelinating disease of central nervous system for many years. Based on the theory of "hidden pathogen", he has preliminarily constructed the syndrome differentiation system of the theory of hidden pathogen. Professor Wang takes the opinion that there was a close relationship between demyelinating disease of the central nervous system in remission stage and Yin-marrow deficiency, wind pathogen internal accumulating, Yang-marrow deficiency, and wind cold dampness internal accumulating. According to the patient′s four diagnostic data, comprehensive analysis of the etiology and pathogenesis, and using syndrome differentiation prescriptions, the treatment methods such as warming Yang engendering essence supplementing marrow, eliminating pathogen dredging collaterals, nourishing Yin supplementing marrow, eliminating pathogen activating collaterals and clearing heat are biult. These treatment methods have significant clinical effects.
|
|
|
|
|
|
[1] Matthews PM，Roncaroli F，Waldman A，et al. A practical review of the neuropathology and neuroimaging of multiple sclerosis [J]. Pract Neurol，2016，16（4）：279-287.
[2] Wingerchuk DM，Banwell B，Bennett JL，et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders [J]. Neurology，2015，85（2）：177-189.
[3] 胡学强，常艳宇.我国多发性硬化诊治现状与进展[J].重庆医科大学学报，2017，6（1）：669-671.
[4] 胡学强，麦卫华，王敦敬.多发性硬化413例患者的临床表现特点[J].中华神经科杂志，2004，1（1）：11-14.
[5] 矫毓娟，王化冰，卢晓宇，等.视神经脊髓炎谱系疾病的认识变迁[J].中华医学杂志，2016，96（37）：3029-3031.
[6] Ramagopalan SV，Dyment DA，Valdar W，et al. Autoimmune disease in families with multiple sclerosis：a population-based study [J]. Lancet Neurol，2007，6（7）：604-610.
[7] 万毅，曾文颖，张会莲.周绍华教授温补法治疗多发性硬化经验[J].中华中医药杂志，2011，11（1）：2599-2601.
[8] Barcellos LF，Kamdar BB，Ramsay PP，et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis：a descriptive study [J]. Lancet Neurol，2006， 5（11）：924-931.
[9] Milo R，Kahana E. Multiple sclerosis：geoepidemiology，genetics and the environment [J]. Autoimmun Rev，2010，9（5）：A387-A394.
[10] Sewell DL，Reinke EK，Hogan LH，et al. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections [J]. Immunol Lett，2002，82（1/2）：101-110.
[11] Sahraian MA，Moghadasi AN，Azimi AR，et al. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder（NMOSD）in Iran：A consensus guideline and recommendations [J]. Mult Scler Relat Disord，2017，18（1）：144-151.
[12] 中国免疫学会神经免疫学分会，中华医学会神经病学分会神经免疫学组，中国医师协会神经内科分会神经免疫专业委员会.中国视神经脊髓炎谱系疾病诊断与治疗指南[J].中国神经免疫学和神经病学杂志，2016，3（1）：155-166.
[13] Yang CS，Yang L，Li T，et al. Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica [J]. Neurology，2013，81（8）：710-713.
[14] Feinstein A，Freeman J，Lo AC. Treatment of progressive multiple sclerosis：what works，what does not，and what is needed [J]. Lancet Neurol，2015，14（2）：194-207.
[15] 马广斌.中西医结合治疗视神经脊髓炎探微[J].光明中医，2010，4（1）：659-660.
[16] 王苏，樊永平，张永超，等.不同中医证型视神经脊髓炎患者临床特点比较[J].环球中医药，2014，11（1）：833-835.
[17] 樊永平，张庆.多发性硬化症状的中医诠译、脏腑属性分析[J].首都医科大学学报，2013，6（1）：885-890.
[18] 孟闯，付菊花，马云枝.马云枝教授治疗多发性硬化经验[J].中国民间疗法，2010，12（1）：10-11.
[19] 樊永平，张庆，周莉.多发性硬化缓解期中医补肾为主减少复发[J].中华中医药杂志，2008，6（1）：504-508.
[20] 李青，詹文涛.詹文涛教授从虚损论治多发性硬化经验[J].云南中医中药杂志，2008，11（1）：1-2. |
|
|
|
